RankingsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Revenue

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥91.7B
P/E ratio
29.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202533,072-22.86%
Mar 31, 202442,871+24.83%
Mar 31, 202334,343-32.77%
Mar 31, 202251,082+69.79%
Mar 31, 202130,085+21.40%
Mar 31, 202024,781+7.00%
Mar 31, 201923,160+12.46%
Mar 31, 201820,594+13.87%
Mar 31, 201718,085+3.71%
Mar 31, 201617,438+3.46%
Mar 31, 201516,856+7.32%
Mar 31, 201415,706+11.39%
Mar 31, 201314,100+9.77%
Mar 31, 201212,845

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)